Dr. Green’s Biomaterials and Drug Delivery Laboratory is interested in biomaterials, drug delivery, gene therapy, nanobiotechnology, and cell engineering. Research findings — and the technologies developed — are applied in the fields of ophthalmology, oncology, and regenerative medicine.
The lab works within the chemistry/biology/engineering interface to answer fundamental scientific questions, and to create innovative technologies and therapeutics that can directly benefit human health.
Current projects include:
- Development of safe and effective biodegradable nanoparticles for DNA and siRNA delivery to treat cancer
- Polymeric microparticle-based biological treatments for age-related macular degeneration
- Design of biomimetic artificial antigen presenting cells for immunoengineering
- Enabling technologies for tissue engineering and regenerative medicine
- Herschel L. Seder Professor, Biomedical Engineering
- Vice Chair for Research and Translation, Department of Biomedical Engineering
- Professor, Ophthalmology
- Professor, Oncology
- Professor, Neurosurgery
- Professor, Materials Science & Engineering
- Professor, Chemical & Biomolecular Engineering
Affiliated Centers & Institutes
- PhD, Biological Engineering, Massachusetts Institute of Technology, 2007
- BS, Chemical Engineering, Biomedical Engineering, Carnegie Mellon University, 2003
June 29, 2023Tests in mice with melanoma and colon cancer show tiny particle creates an “army” of immune cells that carry vaccine’s instructions, researchers say.
January 21, 2022Through advances in biomaterials, stem cell science, and more, researchers are moving tantalizingly close to regenerating damaged body parts, creating new organs, and equipping our existing tissues to fight off debilitating diseases.
January 6, 2022Johns Hopkins Medicine researchers have developed a color-coded test that quickly signals whether newly developed nanoparticles deliver their cargo into target cells.